Skip to content

Clinical study of Jianpi Yanggan Decoction combined with Tongluo Yanggan application in the treatment of autoimmune hepatitis

Efficacy evaluation and mechanism study of Yiqi Huashi and Jiedu Tongluo methods in chronic liver disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2022000094
Enrollment
Unknown
Registered
2022-09-17
Start date
2022-09-26
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Hepatitis

Interventions

Treatment group:Jianpi Yanggan Decoction combined with Tongluo Yanggan application

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for autoimmune hepatitis; 2. Meet the diagnostic criteria of Ganyu and PiXu; 3. The age is between 18-65 years old, and the gender is not limited; 4. Willing to participate in this research and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with liver damage caused by other reasons (such as viral, drug, alcoholic and non-alcoholic fatty liver disease, etc.); 2. Those with acute severe complications, those with critical illnesses such as liver cirrhosis, decompensated hepatic encephalopathy, and liver failure; 3. Pregnant or lactating women, those with allergic constitution; 4. Patients with mental disorders who cannot cooperate with this study; 5. Patients with severe heart, brain, lung, kidney, hematopoietic, immune and other system diseases; 6. Other conditions deemed inappropriate by the researcher.

Design outcomes

Primary

MeasureTime frame
liver function;Immunoglobulin;

Secondary

MeasureTime frame
VAS;TCM symptoms;LSM;FFS;liver ultrasound;

Countries

China

Contacts

Public Contactlvwenliang

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

lvwenliang@sohu.com18601237779

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026